Suchergebnisse - "Antirheumatic Agents"

PubPharm (30.216)

41

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND) : 3-year results from an open-label, randomised controlled, non-inferiority trial

enthalten in: The Lancet. Rheumatology | 2024

von Kjørholt, K. | Sundlisæter, N. | Aga, A. | +19

42

Non-thyroidal disease syndrome in patients with systemic lupus erythematosus : relation to disease inflammatory activity

enthalten in: Clinical rheumatology | 2024

von Meng, X. | Lv, A. | Tang, M. | +9

43

Letter to the Editor : "Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis"

enthalten in: Clinical rheumatology | 2024

von Yu, T. | Qian, S. | Li, M.

CommentOn: Clin Rheumatol. 2022 Dec;41(12):3697-3706. - PMID 35945466

44

Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

enthalten in: The Lancet. Rheumatology | 2024

von van Mulligen, E.

45

Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease : a cohort study from the German RABBIT register

enthalten in: RMD open | 2024

von Rudi, T. | Zietemann, V. | Meissner, Y. | +6

46

Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020 : A Systematic Review

enthalten in: Medicina (Kaunas, Lithuania) | 2024

von Schlegel, M. | Bachmann, S.

47

A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis : data from the NOR-DMARD study

enthalten in: Scandinavian journal of rheumatology | 2024

von Provan, S. | Ahlfors, F. | Bakland, G. | +6

48

'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab Biosimilar

enthalten in: Advances in therapy | 2024

von Gaylis, N. | Both, C. | Lemke, L. | +2

49

Subtherapeutic hydroxychloroquine concentration is associated with increased disease activity and greater organ damage in lupus

enthalten in: Rheumatology (Oxford, England) | 2024

von Kang, J. | Choi, S. | Park, D. | +1

50

A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures

enthalten in: Rheumatology (Oxford, England) | 2024

von Ling, S. | Yap, C. | Nair, N. | +7